Hepatology forum. 2022 Apr 26;3(2):57-60. doi: 10.14744/hf.2021.2021.0011 Q32.12025

Clinical follow-up of patients with HBeAg positive chronic hepatitis B infection: A long-term observational study

乙型肝炎e抗原阳性慢性乙肝患者临床随访研究：一项长期观察性研究 翻译改进

作者单位 +展开

DOI: 10.14744/hf.2021.2021.0011 PMID: 35783475

摘要 Ai翻译

Copyright © Hepatology forum. 中文内容为AI机器翻译，仅供参考！

相关内容

• HCC risk in patients who are HBeAg-positive and have chronic hepatitis B under long-term nucleos(t)ide analogue therapy: New insights from Asia

  长期接受核苷酸类似物治疗的慢性乙型肝炎且HB-e抗原阳性的患者患HCC的风险：来自亚洲的新见解

  George Papatherodoridis

  Hepatology (Baltimore, Md.). 2024 Feb 16.

• Sequential combination therapies for HBeAg-positive chronic hepatitis B: the search continues

  乙型肝炎e抗原阳性慢性乙肝的序贯联合治疗：任重而道远

  Ankur Jindal

  Hepatology international. 2021 Feb;15(1):1-3.

• HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?

  乙型肝炎e抗原阳性慢性乙肝：为什么我要给我的患者使用核苷(酸)类似物？

  Maria Buti

  Liver international : official journal of the International Association for the Study of the Liver. 2014 Feb:34 Suppl 1:108-11.

• Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues

  用核苷类似物治疗HBeAg阳性的慢性乙型肝炎患者

  Nancy Leung

  Liver international : official journal of the International Association for the Study of the Liver. 2011 Jan:31 Suppl 1:85-9.

• Controlled trial with human lymphoblastoid interferon among HBeAg and anti-HBe-positive chronic hepatitis B patients in Egypt

  埃及HBeAg和抗HBe阳性慢性乙型肝炎患者使用人类淋巴母细胞干扰素的临床试验

  A El-Zayadi et al.

  The Journal of the Egyptian Public Health Association. 1995;70(5-6):579-94.

• [A retrospective follow-up study of prolonged nucleos(t)ide analogue and interferon combination therapy in HBeAg-positive chronic hepatitis B patients]

  乙型肝炎e抗原阳性慢性乙型肝炎患者长期核苷(酸)类似物与干扰素联合治疗的回顾性分析研究

  Shu-Li Yu

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2013 Apr;21(4):267-70.

• A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B

  克立夫定治疗乙型肝炎病毒e抗原阳性慢性乙肝患者效果良好且持续时间长（为期12周）

  Hyo-Suk Lee et al.

  Hepatology (Baltimore, Md.). 2006 May;43(5):982-8.

• A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B

  治疗乙肝e抗原阳性的慢性乙型肝炎患者的口服LB80380的随机、安慰剂对照剂量探索研究

  Man-Fung Yuen et al.

  Antiviral therapy. 2006;11(8):977-83.